Current Pharmaceutical Design
Current Pharmaceutical Design is a subscription journal published by Bentham Science Publishers in the Netherlands. OpenAlex counts 11,372 works from it, cited 441,472 times; its h-index is 226. Its two-year mean citedness, which is computed the way the impact factor is, is 3.59: a paper it published in the two years before was cited about 3.59 times last year. It published 327 papers in 2025, about as many as in 2024.
- Publisher
- Bentham Science Publishers
- Citations per paper
- 3.59 two-year mean, OpenAlex
- h-index
- 226 i10-index 7,538
- Access
- Subscription
- ISSN
- 1381-6128, 1873-4286
- Country
- Netherlands
- Works published
- 11,372 cited 441,472 times
- Papers in 2025
- 327
- Website
- Journal home ↗
Current Pharmaceutical Design year by year
Papers it published each year, and the citations all its papers received that year.
| Year | Papers published | Citations received |
|---|---|---|
| 2026 so far | 392 | 21,262 |
| 2025 | 327 | 28,807 |
| 2024 | 327 | 30,170 |
| 2023 | 301 | 28,732 |
| 2022 | 314 | 29,865 |
| 2021 | 295 | 30,404 |
| 2020 | 736 | 29,207 |
| 2019 | 588 | 24,287 |
What Current Pharmaceutical Design publishes
Its most frequent research topics, by OpenAlex's topic classification.
- Nanoparticle-Based Drug DeliveryBiomaterials · 838 papers
- Computational Drug Discovery MethodsDrug Discovery · 708 papers
- Advanced Drug Delivery SystemsPharmaceutical Science · 679 papers
- Alzheimer's disease research and treatmentsCellular and Molecular Neuroscience · 325 papers
- Nitric Oxide and Endothelin EffectsPhysiology (medical) · 280 papers
Questions about Current Pharmaceutical Design
What is the impact factor of Current Pharmaceutical Design?
Clarivate's Journal Impact Factor is licensed and not shown here. OpenAlex's two-year mean citedness, computed the same way from open data, is 3.59 for Current Pharmaceutical Design: on average, each paper it published in the two years before was cited about 3.59 times in a year.
What is the h-index of Current Pharmaceutical Design?
226, by OpenAlex's count: 226 of its papers have each been cited at least 226 times. Its i10-index is 7,538.
Is Current Pharmaceutical Design open access?
Not fully. Current Pharmaceutical Design is a subscription journal; a paper is free to read when its authors paid for open access or posted a copy in a repository.
What is the ISSN of Current Pharmaceutical Design?
Its linking ISSN is 1381-6128; all its ISSNs: 1381-6128, 1873-4286.
Who publishes Current Pharmaceutical Design?
Bentham Science Publishers, based in the Netherlands.
How many papers does Current Pharmaceutical Design publish a year?
327 in 2025, by OpenAlex's count of what it published that year.
What does Current Pharmaceutical Design publish?
Its most frequent research topics are Nanoparticle-Based Drug Delivery, Computational Drug Discovery Methods, Advanced Drug Delivery Systems, in the field of Pharmacology, Toxicology and Pharmaceutics.
Is Current Pharmaceutical Design a predatory journal?
Nothing in the scholarly indexes suggests so. Current Pharmaceutical Design is on OpenAlex's list of core sources, journals with peer review and an editorial board, it has published 11,372 works cited 441,472 times. For a journal you do not know, check the red flags with our predatory journal checker.
Is Current Pharmaceutical Design indexed in Scopus or Web of Science?
Check the Scopus Sources list and Clarivate's Master Journal List by its ISSN (1381-6128): both are free to search. Our guide on checking journal indexing shows each step.
Journals like Current Pharmaceutical Design
Other Pharmacology, Toxicology and Pharmaceutics journals with a similar impact.
Every Pharmacology, Toxicology and Pharmaceutics journal, ranked · The journal directory
Journal data from OpenAlex (CC0), compiled 21 November 2026. Download the whole directory as a CSV file (CC BY 4.0).